Universal-Beteiligungs- und Servicegesellschaft’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.89M Sell
31,459
-25,143
-44% -$3.67M 0.01% 876
2026
Q1
$5.5M Sell
56,602
-9,025
-14% -$911K 0.01% 831
2025
Q4
$5.23M Sell
65,627
-13,105
-17% -$859K 0.01% 872
2025
Q3
$3.68M Buy
78,732
+7,421
+10% +$291K 0.01% 1012
2025
Q2
$2.62M Buy
71,311
+5,060
+8% +$194K ﹤0.01% 1098
2025
Q1
$2.34M Buy
+66,251
New +$2.69M ﹤0.01% 1109

Other funds holding RVMD

Universal-Beteiligungs- und Servicegesellschaft's RVMD Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Revolution Medicines (RVMD) stake by 44% in Q2 2026, selling an estimated $3.67M and leaving 31,459 shares worth $5.89M. The position accounts for 0.01% of the portfolio, ranked #876.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 31,459 shares of Revolution Medicines worth $5.89M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 25,143 Revolution Medicines shares in Q2 2026, an estimated $3.67M.
  • Revolution Medicines made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #876 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.